OUR
Publications
PUBLICATIONS
Emerging concepts towards a translational framework in Alzheimer’s disease
Neuroscience & Biobehavioral Reviews, May 2023
The unfolded protein response transcription factor XBP1s ameliorates Alzheimer’s disease by improving synaptic function and proteostasis
Molecular Therapy, Apr 2023
Promoting diversity and overcoming publication barriers in Latin American neuroscience and Alzheimer’s disease research: A call to action.
Alzheimer's and Dementia, Mar 2023
Brain FNDC5/Irisin Expression in Patients and Mouse Models of Major Depression.
eNeuro, Feb 2023
Cerebrospinal fluid irisin and lipoxin A4 are reduced in elderly Brazilian individuals with depression: Insight into shared mechanisms between depression and dementia.
Alzheimer's and Dementia, Dec 2022
Age-linked suppression of lipoxin A4 associates with cognitive deficits in mice and humans.
Translational Psychiatry, Oct 2022
Irisin stimulates protective signaling pathways in rat hippocampal neurons.
Frontiers in Cellular Neuroscience, Sep 2022
Trace amine-associated receptor 1 modulates motor hyperactivity, cognition, and anxiety-like behavior in an animal model of ADHD.
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Jul 2022
Editorial: Honouring John Hardy – A true pioneer in research.
Journal of Neurochemistry, May 2022
How does the skeletal muscle communicate with the brain in health and disease?
Neuropharmacology, Oct 2021